Site Alert

Our public website content will be unavailable between 6 a.m. and 7 a.m. on Friday, September 20, 2019 for system upgrades.  We apologize for any inconvenience.

Coverage Decisions for Drugs

Local anesthetics

Coverage decision

L&I covers lidocaine 5% patch and lidocaine 2.5% with prilocaine 2.5% cream for FDA indications with prior authorization when the condition is related to the industrial injury or occupational disease.

Lidocaine and prilocaine are local anesthetics thought to stabilize neuronal membranes. Lidocaine 5% patch is approved to relieve pain associated with post-herpetic neuralgia while lidocaine with prilocaine cream is indicated for local analgesia.

The Food and Drug Administration (FDA) has approved the following products:

  • Lidoderm® (lidocaine 5% patch) to relieve pain associated with post-herpetic neuralgia.
  • EMLA® (lidocaine 2.5% with prilocaine 2.5% cream) is indicated for use on normal intact skin for local analgesia.

End of main content, page footer follows.

Access Washington official state portal

   © Washington State Dept. of Labor & Industries. Use of this site is subject to the laws of the state of Washington.

Help us improve